IDO1 and neoplasm: Dendritic cells present in negative SLN appear to be more tolerogenic than those within the primary tumour because, although the median expression of ILT3 remains stable, the expression of both IDO and TGFβ1 increases (IDO 4.02, TGFβ1 2.37; Table 1).